LB Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	931	563	-	-	-
Enterprise Value	568.53	271.52	0	0	0
Last Close Price	32.46	22.26	-	-	-
PB Ratio	2.47	1.87	-	-	-
P/TBV Ratio	2.46	0.59	-	-	-
Debt / Equity Ratio	0.01	0.01	0.16	0	-1.12
Net Debt / Equity Ratio	-0.96	-0.97	0.26	1.26	-0.09
Net Debt / EBITDA Ratio	7.86	9.70	0.38	3.81	-0.98
Net Debt / FCF Ratio	-	8.27	0.45	3.57	-1.01
Quick Ratio	33.53	39.67	3.45	16.61	45.64
Current Ratio	35.68	41.44	3.56	17.51	45.82
Return on Equity (ROE)	-11.46%	-15.70%	-206.22%	-63.14%	66.37%
Return on Assets (ROA)	-13.05%	-17.55%	-163.73%	-33.89%	-13.07%
Return on Invested Capital (ROIC)	-321.34%	-376.51%	-2510.40%	-87521.60%	-93639.90%
Return on Capital Employed (ROCE)	-13.39%	-18.38%	-189.35%	-35.51%	-13.36%
Buyback Yield / Dilution	-4085.30%	-2145.81%	-24.75%	-24.27%	-
Total Shareholder Return	-4085.30%	-2145.81%	-24.75%	-24.27%	-

SEC Filings: 10-K · 10-Q